10EQUATIR

10EQUATIR is a cannabinoid-based pharmaceutical product developed by BOL Pharma (Breath of Life Pharma). It is formulated as medicated drops containing a balanced 1:1 ratio of delta-9-tetrahydrocannabinol (THC 10%) and cannabidiol (CBD 10%). The product is derived from whole-plant extracts or isolated cannabinoids and is designed to leverage the synergistic effects of the endocannabinoid system. It is primarily indicated for the management of symptoms associated with HIV/AIDS (including appetite loss, neuropathic pain, and dementia), multiple sclerosis (pain and spasticity), and Parkinson's disease. The drug is currently approved and marketed in specific jurisdictions, such as Israel, under medical cannabis regulations.

Brand names

10EQUATIR

Other names

THC 10% / CBD 10% dropsBOL-10EQUATIRBOL10EQUATIRBOL 10EQUATIR